Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Longboard Pharmaceuticals
Eli Lilly and Company
Monteris Medical
Longboard Pharmaceuticals
VitaMed Research LLC
Taiho Oncology, Inc.
MedtronicNeuro
Medtronic Spinal and Biologics
ES Therapeutics Australia Pty Ltd
Eli Lilly and Company
Takeda
UCB Pharma
Eli Lilly and Company
GlaxoSmithKline
GlaxoSmithKline